Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain

European Journal of Neuroscience

Volumn 10, Issue 12, 1998, Pages 3607-3616

  Martres, Marie Pascale ^a   Demeneix, Barbara ^b   Hanoun, Naïma ^a   Hamon, Michel ^a   Giros, Bruno ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Polyethylenimine; Striatum; Substantia nigra; Uptake

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; DOPAMINE METABOLISM; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; GENE TRANSFER; MALE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; STEREOTAXIS; SUBSTANTIA NIGRA;

EID: 0032449373     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00366.x     Document Type: Article

References (56)

1. Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J.P. & Demeinex, B. (1996) A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther., 7, 1947-1954.
2. Adelbrecht, C., Liu, Y., Edwards, R.H., Bloch, B., Giros, B., Agid, Y. & Raisman-Vozari, R. (1998) Ontogeny of dopaminergic transporters in the nigrostriatal and mesolimbic pathways in the mouse. Dev. Brain Res., in press.
3. Akli, S., Caillaud, C., Vigne, E., Stratford-Perricaudet, L.D., Poenaru, L., Perricaudet, M., Kahn, A. & Peschanski, M.R. (1993) Transfer of a foreign gene into brain using adenovirus vectors. Nature Genet., 3, 224-228.
4. Amara, S.G. & Kuhar, M.J. (1993) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci., 16, 73-93.
5. 6 receptor in rat brain: a study using antisense oligonucleotides. J. Pharmacol. Exp. Ther., 274, 173-180.
6. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M., Scherman, D., Demeinex, B. & Behr, J.P. (1995) A novel, versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA, 92, 7297-7303.
7. Boviatsis, E.J., Chase, M., Wei, M.X., Tamiya, T., Hurford, R.K., Kowall, N.W., Tepper, R.I., Breakefield, X.O. & Chiocca, E.A. (1994) Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus and retro-virus vectors. Hum. Gene Ther., 5, 183-191.
8. Chambers, R., Gillespie, G.Y., Soroceanu, L., Andreansky, S., Chatterjee, S., Chou, J., Rotzman, B. & Whitley, R.J. (1995) Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a seid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. USA, 92, 1411-1415.
9. Crystal, R.G. (1995) The gene as the drug. Nature Med., 1, 15-17.
10. Crystal, R.G. (1996) Transfer of genes to humans: early lessons and obstacles to success. Science, 270, 404-410.
11. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H. & Blaese, R.M. (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 256, 1550-1552.
12. 3 receptor in the rat brain. Neuroscience, 65, 731-745.
13. During, M.J., Naegele, J.R., O'Malley, K.L. & Geller, A.I. (1994) Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science, 266, 1399-1403.
14. Fisher, L.J. & Ray, J. (1994) In vivo and ex vivo gene transfer to the brain. Curr. Opin. Neurobiol., 4, 735-741.
15. Fleckenstein, A.E., Pögün, S., Carroll, F.I. & Kuhar, M.J. (1996) Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3β-(3p-chlorophenyl) tropan-2β-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride). J. Pharmacol. Exp. Ther., 279, 200-206.
16. Gérard, C., Martres, M.-P., Lefèvre, K., Miquel, M.-C., Vergé, D., Lanfumey, L., Doucet, E., Hamon, M. & El Mestikawy, S. (1997) Immuno-localization of serotonin 5-HTg receptor-like material in the rat central nervous system. Brain Res., 746, 207-219.
17. Giros, B. & Caron, C.G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci., 14, 43-49.
18. Giros, B., El Mestikawy, S., Bertrand, L. & Caron, M.G. (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett., 295, 149-154.
19. Giros, B., El Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yan-Feng, T. & Caron, M.G. (1992) Cloning, pharmacological characterization and chromosomal assignment of the human dopamine transporter. Mol. Pharmacol., 42, 383-390.
20. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. & Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
21. 1A agonists with potential anxiolytic properties. J. Pharmacol. Exp. Ther., 246, 745-752.
22. Horellou, P., Vigne, E., Castel, M.N., Barnéoud, P., Colin, P., Perricaudet, M., Delaère, P. & Mallet, J. (1994) Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport, 6, 49-53.
23. Horn, A.S. (1990) Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol., 34, 387-400.
24. Javitch, J.A., D'Amato, R.J., Strittmater, S.M. & Snyder, S. (1985) Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA, 82, 2173-2177.
25. Jiao, S., Gurevich, V. & Wolff, J. (1993) Long-term correction of rat model of Parkinson's disease by gene therapy. Nature, 362, 450-453.
26. Kaplitt, M.G., Leone, P., Salmuski, R., Xiao, X., Pfaff, D.W., O'Malley, K.L. & During, M.J. (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet., 8, 148-153.
27. Kesari, S., Randazzo, B.P., Valyi-Nagi, T., Huang, Q.S., Brown, S.M., Maclean, A.R., Lee, V.M., Trojanowski, J.Q. & Fraser, N.W. (1995) Therapy of experimental human brain tumors using a neuro attenuated herpes simplex virus mutant. Lab. Invest., 73, 636-648.
28. Kilty, J.E., Lorang, D. & Amara, S.G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science, 254, 578-579.
29. Kuhar, M.J., Ritz, M.C. & Roja, J.W. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci., 14, 299-302.
30. Le Gal La Salle, G., Robert, J.J., Berrard, S., Ridoux, V., Stradford-Perricaudet, L.D., Perricaudet, M. & Mallet, J. (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science, 259, 988-990.
31. Lindvall, O. & Björklund, A. (1978) Anatomy of the dopaminergic neuron systems in the rat brain. Adv. Biochem. Psychopharmacol., 19, 1-23.
32. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, A.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
33. Lucas, J.J. & Hen, R. (1995) New players in the 5-HT receptor field: genes and knock-outs. Trends Neurosci., 16, 246-252.
34. Ono, T., Fujino, Y., Tsuchiua, T. & Tsuda, M. (1990) Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed in brain cells. Neurosci. Lett., 117, 259-263.
35. Pakzaban, P., Geller, A.I. & Isacson, O. (1994) Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a Herpes simplex amplicon vector in the rat brain. Hum. Gene Ther., 5, 987-995.
36. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London, UK.
37. Pifl, C., Giros, B. & Caron, M.G. (1993) Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neuroscience, 13, 4246-4253.
38. 2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat. Synapse, 26, 199-208.
39. Ridet, J.-L. & Privat, A. (1995) Gene therapy in the central nervous system: direct versus indirect gene delivery. J. Neurosci. Res., 42, 287-293.
40. Ritz, M.C., Lamb, R.J., Goldberg, S.R. & Kuhar, M.J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science, 237, 1219-1223.
41. Roessler, B.J. & Davidson, B.L. (1994) Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. Neurosci. Lett., 167, 5-10.
42. Sabaté, O., Horellou, P., Vigne, E., Colin, P., Perricaudet, M., Buc-Caron, M.-H. & Mallet, J. (1995) Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirus. Nature, 9, 256-260.
43. Sahenk, Z., Seharaseyon, J., Mendell, J.R. & Burghes, A.H. (1993) Gene delivery to spinal motor neurons. Brain Res., 606, 126-129.
44. Schwartz, B., Benoist, C., Abdallah, B., Rangara, R., Hassan, A., Scherman, D. & Demeinex, B. (1996) Gene transfer by naked DNA into adult mouse brain. Gene Ther., 3, 405-411.
45. Shimada, S., Kitayama, S., Lin, C.H., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M. & Uhl, G. (1991) Cloning and expression of a cocaine-sensitive dopamine complementary DNA. Science, 254, 576-578.
46. Silvia, C.P., Jaber, M., King, G.R., Ellinwood, E.H. & Caron, M.G. (1997) Cocaine and amphetamine elicit differential effects in rats with unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience, 76, 737-747.
47. 2 autoreceptors in the motor action of cocaine. Mol. Pharmacol., 46, 51-57.
48. Snyder, E.Y., Taylor, R.M. & Wolfe, J.H. (1995) Neural progenitor cell engrafment corrects lysosomal storage throughout the MPS VII mouse brain. Nature, 374, 367-370.
49. 3) as a target for neuroleptics. Nature, 347, 146-151.
50. Standifer, K.M., Chien, C.C., Wahlestedt, C., Brown, G.P. & Pasternak, G.W. (1994) Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron, 12, 805-810.
51. 3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neuroscience, 17, 2519-2530.
52. Wahlestedt, C., Pich, E.M., Koob, G.F. & Heiling, M. (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides. Science, 259, 528-531.
53. 2-mediated behaviors. Neurochem. Int., 31, 571-580.
54. Wood, M.J., Byrnes, A.P., Pfaff, D.W., Rabkin, S.D. & Charlton, H.M. (1994) Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther., 1, 283-291.
55. Zhang, M. & Creese, I. (1993) Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci. Lett., 161, 223-226.
56. Zhang, L.X., Wu, M. & Han, J.S. (1992) Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector. Neuroreport, 3, 700-702.